• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
INTS

INTS

Intensity Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD4.02

-0.26 (-6.07%)

Rating:C

Company Profile

CEO

Lewis H. Bender

IPO Date

2023-06-30

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$4.29

Prev. Close

$4.28

Day Low

$3.95

Day High

$4.32

52W Low

$3.95

52W High

$43.50

Market Cap

$0.01B

Volume

0.04M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

3

Hold

0

Sell

0

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
20 Aug 2025BenchmarkSpeculative BuySpeculative Buymaintain
12 Aug 2025Brookline CapitalHoldBuyupgrade
21 Nov 2024HC Wainwright & Co.BuyBuymaintain
11 Jul 2024
Benchmark
Speculative Buy
Speculative Buy
maintain
16 May 2024BenchmarkSpeculative BuySpeculative Buymaintain
21 Mar 2024BenchmarkSpeculative BuySpeculative Buymaintain
14 Nov 2023BenchmarkSpeculative BuySpeculative Buymaintain
24 Aug 2023BenchmarkSpeculative BuySpeculative Buymaintain